HENDERSON, Nev.--(BUSINESS WIRE)--BodyTel Scientific, Inc. (OTCBB:BDYT), an American company listed on the NASDAQ Over the Counter Bulletin Board and the Frankfurt Stock Exchange, Germany’s largest stock exchange, announced today that the company will exercise its option to acquire the remaining 50% interest in GlucoTel Scientific from Safe-com GmbH & Co. KG and become 100% owner of the German technology. GlucoTel Scientific Inc., the developer of the world’s first and only wireless Bluetooth™ enabled blood glucose meter, is now a wholly owned subsidiary of the company.
